Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ETON.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 67.61%
March 31, 2026 60.72%
December 31, 2025 61.56%
September 30, 2025 34.97%
June 30, 2025 63.00%
March 31, 2025 57.06%
December 31, 2024 55.60%
September 30, 2024 61.04%
June 30, 2024 62.00%
March 31, 2024 62.85%
December 31, 2023 49.64%
September 30, 2023 62.65%
June 30, 2023 80.70%
March 31, 2023 63.08%
December 31, 2022 74.84%
Date Value
September 30, 2022 62.69%
June 30, 2022 62.69%
March 31, 2022 67.00%
December 31, 2021 95.40%
September 30, 2021 20.39%
June 30, 2021 95.57%
March 31, 2021 85.33%
December 31, 2020 -270.4%
September 30, 2020
June 30, 2020 -860.0%
March 31, 2020 -84.85%
December 31, 2019 1.31%
September 30, 2019
June 30, 2019
March 31, 2019 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Nektar Therapeutics 98.46%
Pfizer Inc. 62.94%
Elite Pharmaceuticals, Inc. 40.61%
Daré Bioscience, Inc. -294.5%
Liquidia Corp. 93.10%

Gross Profit Margin (Quarterly) Related Metrics